百奥泰跌3.07% 2020年上市即巅峰募19.7亿元

Core Viewpoint - Baiotai (688177.SH) is currently trading at 25.26 yuan, reflecting a decline of 3.07%, and is in a state of share price drop below its initial public offering (IPO) price [1] Group 1: IPO Details - Baiotai was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on February 21, 2020, with an issuance price of 32.76 yuan per share [1] - The total number of shares issued was 60 million, with China International Capital Corporation as the sponsor and representatives being Xie Xianming and Zhao Zeyu [1] - The stock reached a peak price of 78.00 yuan per share on its first trading day [1] Group 2: Fundraising and Financials - The total amount raised from the IPO was 1.966 billion yuan, with a net amount of 1.876 billion yuan after deducting issuance costs [1] - The net fundraising amount was 124 million yuan less than the original plan of 2 billion yuan [1] - The prospectus released on February 17, 2020, indicated that the funds were intended for drug research and development, marketing network construction, and to supplement working capital [1] Group 3: Issuance Costs - The total issuance costs for the IPO amounted to 89.4002 million yuan [1] - The underwriting and sponsorship fees paid to the sponsor and joint lead underwriters (CICC, GF Securities, and Morgan Stanley Huaxin Securities) totaled 77.8302 million yuan [1]